Maravai Lifesciences Holdings Stock Investor Sentiment

MRVI Stock  USD 2.42  0.19  7.28%   
Under 66% of Maravai Lifesciences' investor base is looking to short. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that many investors are alarmed at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.

Comfort Level 34

 Alarmed

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Maravai Lifesciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Maravai Lifesciences Holdings.

Maravai Historical Sentiment

Although Maravai Lifesciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Maravai, such as negative comments on social media and news outlets, may cause fear in the market and push Maravai Lifesciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Maravai.
  

Maravai Lifesciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Maravai Lifesciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Maravai Lifesciences Historical Investor Sentiment

Investor biases related to Maravai Lifesciences' public news can be used to forecast risks associated with an investment in Maravai. The trend in average sentiment can be used to explain how an investor holding Maravai can time the market purely based on public headlines and social activities around Maravai Lifesciences Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Maravai Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Maravai Lifesciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Maravai Lifesciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Maravai Lifesciences.
over three months ago at investing.com         
Maravai lifesci director John DeFord acquires 100,625 in stock
Investing News at Macroaxis
over three months ago at globenewswire.com         
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
Macroaxis News: globenewswire.com
over three months ago at globenewswire.com         
Acquisition by Deford John A of 17500 shares of Maravai Lifesciences at 5.75 subject to Rule 16b-3
Macroaxis News: globenewswire.com
over three months ago at thelincolnianonline.com         
Acquisition by Carl Hull of 175000 shares of Maravai Lifesciences at 5.64 subject to Rule 16b-3
news
over three months ago at thelincolnianonline.com         
Robert W. Baird Cuts Maravai LifeSciences Price Target to 9.00
news
over three months ago at insidermonkey.com         
Maravai LifeSciences Holdings, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over three months ago at news.google.com         
Maravai LifeSciences Holdings, Inc. Just Reported Earnings, And Analysts Cut Their Target Price - Ya...
Google News at Macroaxis
over three months ago at gurufocus.com         
Maravai LifeSciences Holdings Inc Q3 2024 Earnings Call Highlights Navigating ...
Gurufocus Stories at Macroaxis
over three months ago at seekingalpha.com         
Maravai LifeSciences stock plunges percent amid lowered revenue forecast
seekingalpha News
over three months ago at benzinga.com         
This Celanese Analyst Turns Bearish Here Are Top 5 Downgrades For Friday
benzinga news
over three months ago at thelincolnianonline.com         
Maravai LifeSciences Holdings, Inc. Shares Purchased by Kornitzer Capital Management Inc. KS
news
over three months ago at businesswire.com         
Resumen Maravai LifeSciences planea adquirir la empresa de ADN y ARN de Officinae Bio y fomentar la ...
businesswire News
over three months ago at businesswire.com         
Maravai LifeSciences plant die bernahme des DNA- und RNA-Geschfts von Officinae Bio und frdert damit...
businesswire News
over three months ago at businesswire.com         
Maravai LifeSciences prvoit dacqurir les activits ADN et ARN dOfficinae Bio afin de renforcer son so...
businesswire News
over three months ago at businesswire.com         
Samenvatting Maravai LifeSciences wil de DNA- en RNA-activiteiten van Officinae Bio overnemen, waarm...
businesswire News
Far too much social signal, news, headlines, and media speculation about Maravai Lifesciences that are available to investors today. That information is available publicly through Maravai media outlets and privately through word of mouth or via Maravai internal channels. However, regardless of the origin, that massive amount of Maravai data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Maravai Lifesciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Maravai Lifesciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Maravai Lifesciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Maravai Lifesciences alpha.

Maravai Lifesciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Eckert R Andrew of 134409 shares of Maravai Lifesciences subject to Rule 16b-3
12/16/2024
2
Disposition of 25000 shares by Kurt Oreshack of Maravai Lifesciences at 5.03 subject to Rule 16b-3
01/31/2025
3
Acquisition by Christine Dolan of 55775 shares of Maravai Lifesciences subject to Rule 16b-3
02/14/2025
4
Disposition of 2326 shares by Kevin Herde of Maravai Lifesciences at 4.1 subject to Rule 16b-3
02/18/2025
5
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
02/25/2025
6
Acquisition by Deford John A of 31901 shares of Maravai Lifesciences subject to Rule 16b-3
02/28/2025
7
MRVI INVESTOR ALERT Robbins Geller Rudman Dowd LLP Announces that Maravai LifeSciences ...
03/04/2025
8
Gainey McKenna Egleston Announces A Class Action Lawsuit Has Been Filed Against Maravai ...
03/05/2025
9
Deadline Alert Maravai LifeSciences Holdings, Inc. Investors Who Lost Money Urged To Contact Glancy Prongay Murray LLP About Securities Fraud Lawsuit
03/06/2025
10
Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations -- Investors Should ...
03/07/2025
11
MRVI INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lea...
03/10/2025
12
Marvai LifeSciences Holdings, Inc. Shareholders with Large Losses are Encouraged to Contact ...
03/12/2025

Complementary Tools for Maravai Stock analysis

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules